In the last trading session, 6.86 million Humacyte Inc (NASDAQ:HUMA) shares changed hands as the company’s beta touched 1.74. With the company’s per share price at $2.24 changed hands at $0.35 or 18.52% during last session, the market valuation stood at $347.47M. HUMA’s last price was a discount, traded about -345.09% off its 52-week high of $9.97. The share price had its 52-week low at $1.15, which suggests the last value was 48.66% up since then.
Analysts gave the Humacyte Inc (HUMA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.29. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended HUMA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Humacyte Inc (NASDAQ:HUMA) trade information
Instantly HUMA was in green as seen at the end of in last trading. With action 88.24%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -55.64%, with the 5-day performance at 88.24% in the green. However, in the 30-day time frame, Humacyte Inc (NASDAQ:HUMA) is 44.52% up.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 62.67% from its current market value. According to analyst projections, HUMA’s forecast low is 5 with 10 as the target high. To hit the forecast high, the stock’s price needs a -346.43% plunge from its current level, while the stock would need to soar -123.21% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 42.43%. The 2025 estimates are for Humacyte Inc earnings to increase by 84.69%.
HUMA Dividends
Humacyte Inc is expected to release its next quarterly earnings report in June.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.9686% or 4.73 million shares worth $22.7 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.59 shares estimated at $5.81 million under it, the former controlled 1.79% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.62% of the shares, roughly 2.35 shares worth around $5.27 million.
